Our findings suggest that IgETRAP as a new candidate for the treatment of IgE-mediated allergies, and co-administration IgETRAP with B. longum more effectively alleviates food allergy symptoms by reducing effector cell numbers, free IgE levels, and mast cell degranulation. The gene discussed is IGHE; the disease is allergic disease.